Search

What do systematic reviews say?

192 questions · 194 findings · 88 reviews · Schizophrenia

Sort:Best matchNewest Highest certainty Download CSV

No studies found 80 · 41.2%GRADE not reported 58 · 29.9%Very low 31 · 16%Low 17 · 8.8%Moderate 8 · 4.1%High 0 · 0%

Occupational therapy vs delivery by non‐specialists

Quality of life · adults with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Occupational therapy delivered by specialists versus non‐specialists for people with schizophrenia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Combinations of antipsychotic drugs vs single antipsychotic drugs

Quality of life · schizophrenia or related disorders

1 finding from 1 review

Antipsychotic combinations for schizophrenia 2017 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 398 participants
GRADE not reported

FLUPENTHIXOL vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS

Quality of life · patients with schizophrenia

1 finding from 1 review

Flupenthixol versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

FLUPHENAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS

Quality of life · patients with schizophrenia

1 finding from 1 review

Fluphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

HALOPERIDOL vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS

Quality of life · patients with schizophrenia

1 finding from 1 review

Haloperidol versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

PERPHENAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS

Quality of life · patients with schizophrenia

1 finding from 1 review

Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

TRIFLUOPERAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS

Quality of life · patients with schizophrenia

1 finding from 1 review

Trifluoperazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 5 participants
GRADE not reported

Bromperidol decanoate vs other depot antipsychotic drugs

Quality of life · patients with schizophrenia

1 finding from 1 review

Bromperidol decanoate (depot) for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Bromperidol decanoate vs placebo

Quality of life · patients with schizophrenia

1 finding from 1 review

Bromperidol decanoate (depot) for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Technology‐mediated psychoeducation + standard care intervention vs usual care

Quality of life · schizophrenia

1 finding from 1 review

Information and communication technology in patient education and support for people with schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Technology‐mediated psychoeducation vs usual care

Quality of life · schizophrenia

1 finding from 1 review

Information and communication technology in patient education and support for people with schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

SUPPORTIVE THERAPY vs ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT

Quality of life QLS · patients with schizophrenia

1 finding from 1 review

Supportive therapy for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 19 participants
Very low

SUPPORTIVE THERAPY vs PSYCHOEDUCATION

Quality of life QLS · patients with schizophrenia

1 finding from 1 review

Supportive therapy for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 19 participants
Very low

SUPPORTIVE THERAPY vs usual care

Quality of life WBS · patients with schizophrenia

1 finding from 1 review

Supportive therapy for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 260 participants
Very low

SOCIAL SKILLS vs DISCUSSION CONTROL

Quality of life QLS · patients with schizophrenia

1 finding from 1 review

Social skills programmes for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 63 participants
Very low

COMPARISON 1. ARIPIPRAZOLE vs OLANZAPINE

Quality of life: as · patients with schizophrenia

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Very low

SUPPORTIVE THERAPY vs cognitive behavioural therapy

Quality of life RSES · patients with schizophrenia

1 finding from 1 review

Supportive therapy for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 65 participants
Very low

HIV ADVICE vs NO HIV ADVICE

Number of participants with improved quality of life · people with serious mental illness

1 finding from 1 review

HIV prevention advice for people with serious mental illness 2016 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

FLUPHENAZINE (ORAL) vs QUETIAPINE

Quality of life (long term) · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Fluphenazine (oral) versus atypical antipsychotics for schizophrenia 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

VIRTUAL REALITY AS A SOLE METHOD + STANDARD PROFESSIONAL CARE vs usual care

Quality of life: any outcome · patients with treatment compliance for people with serious mental illness

1 finding from 1 review

Virtual reality for treatment compliance for people with serious mental illness 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported